Adenosine-Pathway Targeted Cancer Immunotherapy Summit Media Hub
A Spotlight on the CD73 Cancer Clinical Trial Landscape; Antibodies, Small Molecules, Bispecifics & Beyond
Want to get involved in exploring the latest combinations, biomarkers and clinical updates in the adenosine inhibitor field with Arcus, iTeos, Corvus and more? Follow the links below!
